ILIM
OPTR

Irish Life Investment Managers’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Irish Life Investment Managers’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$40.5K Buy
+2,804
New +$40.8K ﹤0.01% 1564

Other funds holding OPTR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Irish Life Investment Managers's OPTR Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q2 2013: 2,804 shares worth $40.5K. The stake represents ﹤0.01% of the portfolio and ranks #1564 among its holdings.

103 funds tracked by Wall St. Rank hold OPTR as of Q2 2013.

  • Irish Life Investment Managers held 2,804 shares of OPTIMER PHARMACEUTICALS, INC. COM STK worth $40.5K as of Q2 2013.
  • OPTIMER PHARMACEUTICALS, INC. COM STK was a new Irish Life Investment Managers position in Q2 2013.
  • OPTIMER PHARMACEUTICALS, INC. COM STK made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1564 holding.
  • 103 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.